Identification | More | [Name]
Ethyl 2,4,5-trifluorobenzoylacetate | [CAS]
98349-24-7 | [Synonyms]
3-OXO-3-(2,4,5-TRIFLUORO-PHENYL)-PROPIONIC ACID ETHYL ESTER ETHYL 2,4,5-TRIFLUOROBENZOYLACETATE ETHYL 3-(2,4,5-TRIFLUOROPHENYL)-3-OXOPROPANOATE ETHYL 3-OXO-3-(2,4,5-TRIFLUOROPHENYL)PROPANOATE 2,4,5-Triflurobenzoflacetate ETHYL 3-OXO-3(2,4,5-TRIFLUOROPHENYL) PROPIONATE | [Molecular Formula]
C11H9F3O3 | [MDL Number]
MFCD00792431 | [Molecular Weight]
246.18 | [MOL File]
98349-24-7.mol |
Chemical Properties | Back Directory | [Appearance]
off-white crystall powder | [Melting point ]
66-68°C | [Boiling point ]
92 °C(Press: 0.08 Torr) | [density ]
1.319±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
soluble in Toluene | [form ]
powder to crystal | [pka]
10.26±0.50(Predicted) | [color ]
White to Almost white | [InChI]
InChI=1S/C11H9F3O3/c1-2-17-11(16)5-10(15)6-3-8(13)9(14)4-7(6)12/h3-4H,2,5H2,1H3 | [InChIKey]
OTCJYVJORKMTHX-UHFFFAOYSA-N | [SMILES]
C1(C(=O)CC(=O)OCC)C=C(C(F)=CC=1F)F | [CAS DataBase Reference]
98349-24-7(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
C,Xi,T | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [RIDADR ]
UN2811 6.1 | [HazardClass ]
IRRITANT | [HS Code ]
2918300090 |
Hazard Information | Back Directory | [Chemical Properties]
off-white crystall powder | [Uses]
Ethyl 2,4,5-Trifluoro-β-oxobenzenepropanoate can be used to prepare aminopyrrolidinyl)quinolinecarboxylates with antitumor activities. | [Synthesis]
Step 2. Synthesis of ethyl 3-oxo-3-(2,4,5-trifluorophenyl)propionate (B). Referring to the literature method [Wierenga, W.; Skulnick, H. I. J. Org. Chem. 1979, 44, 310-311], a mixture of monoethyl malonate (0.18 mL, 1.50 mmol) with bipyridine (1 crystal) was dissolved in tetrahydrofuran (THF, 10 mL) and cooled to -75 °C under argon protection . At -75 °C, n-butyllithium (n-BuLi, 2.8 mL, 4.48 mmol, 5.9 eq.) was slowly added. The reaction mixture was warmed to -50 °C and held for about 2 minutes until the pink color no longer faded (to ensure that the amount of n-butyllithium was sufficient to form a divalent anion), and then cooled to -75 °C again. Subsequently, a THF solution (2-3 mL) of 2,4,5-trifluorobenzoyl chloride (0.75 mmol) was slowly added. The reaction mixture was gradually warmed to room temperature, diluted with ethyl acetate (50 mL) and acidified with 1N hydrochloric acid under stirring. The organic phase was washed sequentially with 5% sodium bicarbonate solution (30 mL x 2) and saturated saline (50 mL x 2), dried with anhydrous sodium sulfate and concentrated. The oil obtained was purified by silica gel column chromatography (40 g silica gel column, 20% ethyl acetate in hexane solution, 40 min gradient) to give 185 mg (89% yield) of target product B as a white solid. | [References]
[1] Journal of Medicinal Chemistry, 1999, vol. 42, # 19, p. 3899 - 3909 [2] Patent: WO2008/36420, 2008, A2. Location in patent: Page/Page column 45-46 [3] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 168 - 174 |
|
|